398 related articles for article (PubMed ID: 1382903)
1. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
2. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
3. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
[TBL] [Abstract][Full Text] [Related]
4. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC.
Mikhail N; Raska K; Raskova J; Degiannis D
Immunopharmacology; 1993; 25(1):29-36. PubMed ID: 8320080
[TBL] [Abstract][Full Text] [Related]
5. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
Shahabuddin S
J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
[TBL] [Abstract][Full Text] [Related]
6. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
Elg SA; Hill RB; Heldman L; Ramakrishnan S
Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans.
Chopra RK; Holbrook NJ; Powers DC; McCoy MT; Adler WH; Nagel JE
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):297-308. PubMed ID: 2507204
[TBL] [Abstract][Full Text] [Related]
8. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
Jobin N; Garrel D; Bernier J
Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
[TBL] [Abstract][Full Text] [Related]
9. Proliferation, interleukin-2 production and receptor expression in peripheral blood mononuclear cells from colorectal cancer patients.
Chang KJ; Wang SM; Lee CS; Hsieh KH; Chen KM
J Formos Med Assoc; 1990 Mar; 89(3):205-13. PubMed ID: 1974593
[TBL] [Abstract][Full Text] [Related]
10. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor.
Degiannis D; Czarnecki M; Hornung N; Raskova J; Raska K
Transplantation; 1991 Feb; 51(2):518-23. PubMed ID: 1825248
[TBL] [Abstract][Full Text] [Related]
11. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
[TBL] [Abstract][Full Text] [Related]
12. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
Symons JA; Wood NC; Di Giovine FS; Duff GW
J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
[TBL] [Abstract][Full Text] [Related]
13. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
14. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore.
Kakkanaiah VN; Nagarkatti PS; Nagarkatti M
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):533-43. PubMed ID: 1483106
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.
Prin L; Plumas J; Gruart V; Loiseau S; Aldebert D; Ameisen JC; Vermersch A; Fenaux P; Bletry O; Capron M
Blood; 1991 Nov; 78(10):2626-32. PubMed ID: 1726707
[TBL] [Abstract][Full Text] [Related]
16. The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy.
Parera M; Rivera F; Egido J; Campos A
Clin Immunol Immunopathol; 1992 May; 63(2):196-9. PubMed ID: 1351798
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection.
Ward BJ; Johnson RT; Vaisberg A; Jauregui E; Griffin DE
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):236-48. PubMed ID: 1914259
[TBL] [Abstract][Full Text] [Related]
18. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
Duan ZF
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation.
Hashimoto S; Takahashi Y; Tomita Y; Hayama T; Sawada S; Horie T; McCombs CC; Michalski JP
Scand J Immunol; 1991 Apr; 33(4):393-403. PubMed ID: 2017664
[TBL] [Abstract][Full Text] [Related]
20. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.
Barral-Netto M; Barral A; Santos SB; Carvalho EM; Badaro R; Rocha H; Reed SG; Johnson WD
J Immunol; 1991 Jul; 147(1):281-4. PubMed ID: 1904902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
